Product Information
SPRITAM 750 MG TABLET is a brand product labeled by Aprecia Pharmaceuticals, LLC, priced at $10.3781 per EA under NDC 43485010360. Its NADAC has been published 122 times since Apr 17, 2024.
FDA first approved this application on Jul 31, 2015.
The High Outlier badge above means this manufacturer's average price in the levetiracetam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/1
Manufacturer
Aprecia Pharmaceuticals, LLCNDC
43485010360
Classification
Brand
Dosage Form
TABLET, FOR SUSPENSION
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
LEVETIRACETAMApproval Type
New Drug (NDA)
FDA Application
NDA207958FDA Approved
7/31/2015
On Market Since
2/5/2016
Pharmacological Classes
Price Statistics
The NADAC for SPRITAM 750 MG TABLET has been published 122 times since Apr 17, 2024, and over the history we have for it it has risen 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3781 per EA |
|---|---|
| All-time high | $10.4410 (Feb 12, 2025) |
| All-time low | $9.6900 (Apr 17, 2024) |
| 52-week high | $10.3781 |
| 52-week low | $10.3781 |
| Median price | $10.3781 |
| Average price | $10.3521 |
| Largest weekly change | +7.5% (Jun 12, 2024) |
| Weeks tracked | 122 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SPRITAM 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SPRITAM 750 MG TABLET, manufactured by Aprecia Pharmaceuticals, LLC, is $10.3781 per EA (NDC 43485010360), effective Aug 12, 2026.
How has the price of SPRITAM 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for SPRITAM 750 MG TABLET has risen 7.1%. It has been tracked across 122 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SPRITAM 750 MG TABLET?
Since Apr 17, 2024, the NADAC for SPRITAM 750 MG TABLET has ranged from a low of $9.6900 (Apr 17, 2024) to a high of $10.4410 (Feb 12, 2025), with a median of $10.3781 per EA.
Are there cheaper alternatives to SPRITAM 750 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1105 per EA — about 99% below SPRITAM 750 MG TABLET.
Who manufactures SPRITAM 750 MG TABLET?
SPRITAM 750 MG TABLET (NDC 43485010360) is labeled by Aprecia Pharmaceuticals, LLC, and CMS classifies it as a brand product.